Shi Ke, Zhou Tao, Yuan Yu-Fei, Li Dan-Dan, Gong Bin-Bin, Gao Shan, Chen Qi-Jia, Li Yan-Dong, Han Xue
College of Food Science and Biology Hebei University of Science and Technology Shijiazhuang China.
College of Biological Science and Engineering Xingtai University Xingtai China.
Food Sci Nutr. 2023 Jun 15;11(8):4812-4828. doi: 10.1002/fsn3.3459. eCollection 2023 Aug.
Both edible fungal polysaccharides ( and ) and flavonoids promote the balance of dyslipidemia, which have a positive biological regulating effect on intestinal flora. In this study, the extraction of water-soluble polysaccharides from and was investigated and optimized firstly. Polysaccharides and flavonoids were then combined to study the effects on the mediating role of abnormal blood lipid concentration and intestinal flora in vivo. The rats were divided into 10 groups, the NC (normal control), HM (model), PCI (Simvastatin control), PCII (Fenofibrate control), AAP ( Polysaccharide), TFP ( Polysaccharide), HF ( Flavonoid), LDC (Low-dose combination), MDC (Medium dose combination), and HDC (High-dose combination), used to explore the impact of polysaccharides and flavonoids complex on state of blood lipid, liver, and intestinal flora of dyslipidemia rats. The results showed that the combination of polysaccharides and flavonoids could significantly decrease the levels of triglyceride (TG), total cholesterol (TC), low-density lipoprotein (LDL-C), and increase the level of high-density lipoprotein cholesterol (HDL-C). It also significantly decreased the levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) and improved liver morphology. What is more, the HDC favorably alters the intestinal microflora balance, promotes intestinal integrity and mobility, and inhibits the growth of harmful bacteria such as and compared with HM group. In brief, the combination of polysaccharides and flavonoids had a synergistic effect on the remission of dyslipidemia, and promoted health by improving lipid metabolism, protecting liver tissue, and regulating the intestinal flora in hyperlipidemia rats.
食用真菌多糖(和)以及黄酮类化合物均可促进血脂异常的平衡,对肠道菌群具有积极的生物调节作用。在本研究中,首先对从和中提取水溶性多糖进行了研究和优化。然后将多糖和黄酮类化合物结合起来,研究其对体内血脂浓度异常和肠道菌群的介导作用的影响。将大鼠分为10组,即NC(正常对照)、HM(模型)、PCI(辛伐他汀对照)、PCII(非诺贝特对照)、AAP(多糖)、TFP(多糖)、HF(黄酮类化合物)、LDC(低剂量组合)、MDC(中剂量组合)和HDC(高剂量组合),用于探究多糖和黄酮类化合物复合物对血脂异常大鼠的血脂、肝脏和肠道菌群状态的影响。结果表明,多糖和黄酮类化合物的组合可显著降低甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白(LDL-C)水平,并提高高密度脂蛋白胆固醇(HDL-C)水平。它还显著降低了丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)水平,并改善了肝脏形态。此外,与HM组相比,HDC有利于改变肠道微生物群平衡,促进肠道完整性和蠕动,并抑制诸如和等有害细菌的生长。简而言之,多糖和黄酮类化合物的组合对血脂异常的缓解具有协同作用,并通过改善高脂血症大鼠的脂质代谢、保护肝组织和调节肠道菌群来促进健康。